Navigation Links
New SPE Cation Exchange Technology From Varian Simplifies Extraction of Basic Compounds

PALO ALTO, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) announced today the release of Bond Elut Plexa(TM) PCX, a new addition to the Plexa family. Bond Elut Plexa and Plexa PCX comprise an advanced generation of polymers for solid phase extraction (SPE), designed for ease of use and improved analytical performance. SPE is used by analytical chemists to concentrate and clean up compounds of interest from their surrounding sample matrices for analysis by liquid chromatography/mass spectrometry (LC/MS).

Plexa and Plexa PCX are high performance polymers using novel formats and methods for high throughput automation and simple method development. Bond Elut Plexa is a general purpose choice for a wide range of acid, basic and neutral analytes. Plexa PCX is designed specifically to provide a single, simple extraction method for basic compounds. Both are ideal for applications in pharmacokinetics, pharmacodynamics, forensics, toxicology, food safety and environmental investigation.

Plexa PCX uses a polymer cation exchange mechanism that combines the outstanding properties of Bond Elut Plexa -- superior flow characteristics and improved analytical performance -- with strong cation exchange capability. This advanced SPE sorbent effectively removes neutral and acidic interferences from the sample matrix and concentrates basic analytes, resulting in improved sensitivity, quantification and analytical performance.

The Plexa range of SPE products delivers faster flow rates because the particles have much smaller spaces between them with no fines to cause blockages. Results are more reproducible because the polymer particles are more regular and uniform. With Plexa PCX, a simplified, method for basic compounds is possible, reducing development time and costs. In addition, the Plexa range reduces ion suppression because of the unique polymer design -- the particle exterior excludes proteins and avoids strong binding of phospholipids, and so efficient removal of phospholipids from biological samples is ensured.

"Plexa PCX builds on the success of Bond Elut Plexa, offering an exciting new choice for simplified, high performance sample processing", says Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Both products make excellent use of sophisticated polymer resins, supported by optimized methods to provide faster, better SPE results in a high-throughput laboratory environment."

For more technical information about Varian's SPE consumables, please visit

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,800 people and operates manufacturing facilities in 13 locations in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2006 sales of $835 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI". Further information is available on the company's Web site:

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. A Versatile Power Supply for All Electrophoresis Applications
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
4. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
5. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
6. Greater Amplification Specificity with New Hot Start PCR Enzyme
7. Yeast Protein Production System Features High Yields and One-Step Purification
8. Expression and Purification of Recombinant Proteins That Have Native Amino Acid Sequence
9. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
10. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
11. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Vancouver ... lancet that features Owen Mumford,s unique Comfort Zone Technology®. ... Unistik® Touch is a touch activated lancet that features ... Owen Mumford, a leading medical device manufacturer, today unveils ... available initially in the US before expanding out to ...
(Date:12/1/2015)... Dec. 1, 2015 Today the Allen Institute ... Seattle,s South Lake Union neighborhood, the ... Mercer Street and Westlake Avenue North, the 270,000 square ... Institute for Brain Science and the Allen Institute for ... and founder of the Allen Institute. "We started by ...
(Date:12/1/2015)... CAMBRIDGE, Mass. , Dec. 1, 2015 ... and the McGovern Institute for Brain Research at MIT ... system that significantly cut down on "off-target" editing errors. ... issues in the use of genome editing. ... report that changing three of the approximately 1,400 amino ...
(Date:12/1/2015)... -- Twist Bioscience, a company focused on synthetic DNA, today announced ... selected as one of Foreign Policy,s 100 Leading ... of life . Each year, Foreign Policy selects ... have changed lives and are shaping the world. ... to be recognized among these incredible global leaders," said Leproust. ...
Breaking Biology Technology:
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):